Page last updated: 2024-11-01

nevirapine and Central Nervous System Disease

nevirapine has been researched along with Central Nervous System Disease in 6 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Research Excerpts

ExcerptRelevanceReference
"immediate allergy and increased hepatotoxicity (regardless of chronic infection with hepatitis B or C virus and methadone use) for nevirapine."2.71Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. ( Calza, L; Chiodo, F; Manfredi, R, 2004)
"Two hundred and thirty-five (235) AIDS patients who received ART were monitored for ADRs over a period of 6 months."1.36Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study. ( Gupta, U; Kumar, S; Nagpal, M; Tayal, V, 2010)
"The relationships between adverse events (AEs) and plasma concentrations of nevirapine (NVP) and efavirenz (EFV) were investigated as part of the large, international, randomized 2NN study."1.33Are adverse events of nevirapine and efavirenz related to plasma concentrations? ( Baraldi, E; Beijnen, JH; Huitema, AD; Kappelhoff, BS; Lange, JM; MacGregor, TR; Montella, F; Robinson, PA; Russell, DB; Thompson, MA; Uip, DE; van Leth, F, 2005)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pedrol, E1
Llibre, JM1
Tasias, M1
Currán, A1
Guardiola, JM1
Deig, E1
Guelar, A1
Martínez-Madrid, O1
Tikhomirova, L1
Ramírez, R1
Roca, B1
Nagpal, M1
Tayal, V1
Kumar, S1
Gupta, U1
Manfredi, R1
Calza, L1
Chiodo, F1
Kappelhoff, BS1
van Leth, F1
Robinson, PA1
MacGregor, TR1
Baraldi, E1
Montella, F1
Uip, DE1
Thompson, MA1
Russell, DB1
Lange, JM1
Beijnen, JH1
Huitema, AD1

Reviews

1 review available for nevirapine and Central Nervous System Disease

ArticleYear
Pharmacogenomics of antiretrovirals.
    Recent patents on anti-infective drug discovery, 2008, Volume: 3, Issue:2

    Topics: Alkynes; Anti-Retroviral Agents; Aryl Hydrocarbon Hydroxylases; Atazanavir Sulfate; Benzoxazines; Ce

2008

Trials

1 trial available for nevirapine and Central Nervous System Disease

ArticleYear
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study.
    Journal of acquired immune deficiency syndromes (1999), 2004, Apr-15, Volume: 35, Issue:5

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Central Nervous System Diseases

2004

Other Studies

4 other studies available for nevirapine and Central Nervous System Disease

ArticleYear
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study.
    HIV medicine, 2015, Volume: 16, Issue:10

    Topics: Adult; Aged; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Central Nervous System Di

2015
Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study.
    Indian journal of medical sciences, 2010, Volume: 64, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Central Nervous System Diseases; Drug Th

2010
Safe substitution for efavirenz.
    AIDS patient care and STDs, 2004, Volume: 18, Issue:1

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Cyclopropanes; HIV Infectio

2004
Are adverse events of nevirapine and efavirenz related to plasma concentrations?
    Antiviral therapy, 2005, Volume: 10, Issue:4

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Central Nervous System Diseases; Chemical and Drug In

2005